How Racialized Approaches to Opioid Use Disorder and Opioid Misuse Management Hamper Pharmacoequity for Cancer Pain.

Katie Fitzgerald Jones, Kevin T Liou, Rebecca L Ashare, Brooke Worster, Katherine A Yeager, Jessica Merlin, Salimah H Meghani
Author Information
  1. Katie Fitzgerald Jones: Division of Palliative Care, Department of Medicine, New England Geriatric Research, Education, and Clinical Center, VA Boston Healthcare System Boston, MA. ORCID
  2. Kevin T Liou: Department of Medicine, Integrative Medicine Service, Memorial Sloan Kettering Cancer Center New York, NY.
  3. Rebecca L Ashare: Department of Psychology, State University of New York at Buffalo, Buffalo, NY.
  4. Brooke Worster: Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
  5. Katherine A Yeager: Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA.
  6. Jessica Merlin: Section of Palliative Care and Medical Ethics, Division of General Internal Medicine, CHAllenges in Managing and Preventing Pain Clinical Research Center, University of Pittsburgh, Pittsburgh, PA.
  7. Salimah H Meghani: Department of Biobehavioral Health Science, School of Nursing, University of Pennsylvania, Philadelphia, PA.

Abstract

@JCO_ASCO paper focuses on racialized approaches to OUD and opioid misuse as underappreciated drivers of disparities in cancer and recs a path forward.

MeSH Term

Humans
Cancer Pain
Opioid-Related Disorders
Analgesics, Opioid
Healthcare Disparities
Neoplasms
Pain Management

Chemicals

Analgesics, Opioid

Word Cloud

Created with Highcharts 10.0.0Opioid@JCO_ASCOpaperfocusesracializedapproachesOUDopioidmisuseunderappreciateddriversdisparitiescancerrecspathforwardRacializedApproachesUseDisorderMisuseManagementHamperPharmacoequityCancerPain

Similar Articles

Cited By

No available data.